Coincidence between periodontitis and inflammatory bowel disease
Keywords:
Bacteria, Periodontal Disease, Inflammatory Bowel Disease, Gingivitis, PeriodontitisAbstract
After research done in recent years it has been shown that periodontal disease and inflammatory bowel disease can develop, since this is a disease that has been a global health problem with a sustained increasing incidence and when there is a susceptibility in populations that had periodontitis. Inflammatory bowel disease is compromised by host genetics, daily diet, and gut microbiota, and authenticity appears to be shared with those of periodontal disease. The key etiologies of both diseases remain unclear, making it difficult to explore possible links between periodontal disease and inflammatory bowel disease. This study predisposes the coincidences that occur in these two diseases.
Downloads
References
Cai Z, Zhu T, Liu F, Zhuang Z, Zhao L. Co-pathogens in Periodontitis and Inflammatory Bowel Disease. Front Med (Lausanne). 2021 Sep 20;8:723719. doi: 10.3389/fmed.2021.723719
Wei Y, Wang Z, Lei L, Chen L. Global burden of periodontal disease and its relation with socioeconomic development during 1990-2019. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Oct 25;50(5):545-552. English. doi: 10.3724/zdxbyxb-2021-0321.
Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021 Jul;21(7):426-440. doi: 10.1038/s41577-020-00488-6. Epub 2021 Jan 28.
Guan Q. A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J Immunol Res. 2019 Dec 1;2019:7247238. doi: 10.1155/2019/7247238.
She YY, Kong XB, Ge YP, Liu ZY, Chen JY, Jiang JW, et al. doi: 10.1007/s00384-018-3117-4. Epub 2018 Jul 12.
Papageorgiou SN, Hagner M, Nogueira AV, Franke A, Jäger A, Deschner J. Inflammatory bowel disease and oral health: systematic review and a meta-analysis. J Clin Periodontol. 2017 Apr;44(4):382-393. doi: 10.1111/jcpe.12698. Epub 2017 Mar 6.
Malik TF, Aurelio DM. Extraintestinal Manifestations of Inflammatory Bowel Disease. 2022 Mar 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 33760556.
Zhang Y, Qiao D, Chen R, Zhu F, Gong J, Yan F. The Association between Periodontitis and Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Biomed Res Int. 2021 Mar 12;2021:6692420. doi: 10.1155/2021/6692420.
Bunte K, Beikler T. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases. Int J Mol Sci. 2019 Jul 10;20(14):3394. doi: 10.3390/ijms20143394
Zhang L, Gao X, Zhou J, Chen S, Zhang J, Zhang Y, et al. Increased risks of dental caries and periodontal disease in Chinese patients with inflammatory bowel disease. Int Dent J. 2020 Jun;70(3):227-236. doi: 10.1111/idj.12542. Epub 2020 Jan 30.
Chi YC, Chen JL, Wang LH, Chang K, Wu CL, Lin SY, et al. Increased risk of periodontitis among patients with Crohn's disease: a population-based matched-cohort study. Int J Colorectal Dis. 2018 Oct;33(10):1437-1444. doi: 10.1007/s00384-018-3117-4. Epub 2018 Jul 12.
Li JX, Chiang CC, Chen SN, Lin JM, Tsai YY. The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022 Nov 25;19(23):15683. doi: 10.3390/ijerph192315683.
Koutsochristou V, Zellos A, Dimakou K, Panayotou I, Siahanidou S, Roma-Giannikou E, et al. Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease: A Case-Control Study. Inflamm Bowel Dis. 2015 Aug;21(8):1839-46. doi: 10.1097/MIB.0000000000000452.
Lin CY, Tseng KS, Liu JM, Chuang HC, Lien CH, Chen YC, et al. Increased Risk of Ulcerative Colitis in Patients with Periodontal Disease: A Nationwide Population-Based Cohort Study. Int J Environ Res Public Health. 2018 Nov 21;15(11):2602. doi: 10.3390/ijerph15112602.
Jia L, Han N, Du J, Guo L, Luo Z, Liu Y. Pathogenesis of Important Virulence Factors of Porphyromonas gingivalis via Toll-Like Receptors. Front Cell Infect Microbiol. 2019 Jul 18;9:262. doi: 10.3389/fcimb.2019.00262.
Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998 Feb;25(2):134-44. doi: 10.1111/j.1600-051x.1998.tb02419.x.
Kinashi Y, Hase K. Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity. Front Immunol. 2021 Apr 22;12:673708. doi: 10.3389/fimmu.2021.673708.
Zhu J, Ren H, Zhong H, Li X, Zou Y, Han M, et al. An Expanded Gene Catalog of Mouse Gut Metagenomes. mSphere. 2021 Feb 24;6(1):e01119-20. doi: 10.1128/mSphere.01119-20.
Sartor RB, Wu GD. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. Gastroenterology. 2017 Feb;152(2):327-339.e4. doi: 10.1053/j.gastro.2016.10.012. Epub 2016 Oct 18.
Lleal M, Sarrabayrouse G, Willamil J, Santiago A, Pozuelo M, Manichanh C. A single faecal microbiota transplantation modulates the microbiome and improves clinical manifestations in a rat model of colitis. EBioMedicine. 2019 Oct;48:630-641. doi: 10.1016/j.ebiom.2019.10.002. Epub 2019 Oct 15.
Lauritano D, Boccalari E, Di Stasio D, Della Vella F, Carinci F, Lucchese A, et al. Prevalence of Oral Lesions and Correlation with Intestinal Symptoms of Inflammatory Bowel Disease: A Systematic Review. Diagnostics (Basel). 2019 Jul 15;9(3):77. doi: 10.3390/diagnostics9030077.
Yin W, Ludvigsson JF, Liu Z, Roosaar A, Axéll T, Ye W. Inverse Association Between Poor Oral Health and Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2017 Apr;15(4):525-531. doi: 10.1016/j.cgh.2016.06.024. Epub 2016 Jul 5
Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018 Dec;16(12):745-759. doi: 10.1038/s41579-018-0089-x.
Schmidt TS, Hayward MR, Coelho LP, Li SS, Costea PI, Voigt AY, et al. Extensive transmission of microbes along the gastrointestinal tract. Elife. 2019 Feb 12;8:e42693. doi: 10.7554/eLife.42693.
Mysak J, Podzimek S, Sommerova P, Lyuya-Mi Y, Bartova J, Janatova T, et al. Porphyromonas gingivalis: major periodontopathic pathogen overview. J Immunol Res. 2014;2014:476068. doi: 10.1155/2014/476068. Epub 2014 Mar 25.
Jia L, Han N, Du J, Guo L, Luo Z, Liu Y. Pathogenesis of Important Virulence Factors of Porphyromonas gingivalis via Toll-Like Receptors. Front Cell Infect Microbiol. 2019 Jul 18;9:262. doi: 10.3389/fcimb.2019.00262.
Xu W, Zhou W, Wang H, Liang S. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis. Adv Protein Chem Struct Biol. 2020;120:45-84. doi: 10.1016/bs.apcsb.2019.12.001.
Kato T, Yamazaki K, Nakajima M, Date Y, Kikuchi J, Hase K, et al. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome. mSphere. 2018 Oct 17;3(5):e00460-18. doi: 10.1128/mSphere.00460-18.
Zhang Z, Liu D, Liu S, Zhang S, Pan Y. The Role of Porphyromonas gingivalis Outer Membrane Vesicles in Periodontal Disease and Related Systemic Diseases. Front Cell Infect Microbiol. 2021 Jan 28;10:585917. doi: 10.3389/fcimb.2020.585917.
Herridge WP, Shibu P, O'Shea J, Brook TC, Hoyles L. Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses. J Med Microbiol. 2020 Feb;69(2):176-194. doi: 10.1099/jmm.0.001141. Epub 2020 Jan 24.
Otto NA, Pereverzeva L, Leopold V, Ramirez-Moral I, Roelofs JJTH, van Heijst JWJ, et al. Hypoxia-Inducible Factor-1α in Macrophages, but Not in Neutrophils, Is Important for Host Defense during Klebsiella pneumoniae-Induced Pneumosepsis. Mediators Inflamm. 2021 Aug 5;2021:9958281. doi: 10.1155/2021/9958281.
Wu T, Xu F, Su C, Li H, Lv N, Liu Y, et al. Alterations in the Gut Microbiome and Cecal Metabolome During Klebsiella pneumoniae-Induced Pneumosepsis. Front Immunol. 2020 Jul 31;11:1331. doi: 10.3389/fimmu.2020.01331.
Kitamoto S, Nagao-Kitamoto H, Jiao Y, Gillilland MG 3rd, Hayashi A, Imai J, et al. The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis. Cell. 2020 Jul 23;182(2):447-462.e14. doi: 10.1016/j.cell.2020.05.048. Epub 2020 Jun 16.
Liu F, Ma R, Wang Y, Zhang L. The Clinical Importance of Campylobacter concisus and Other Human Hosted Campylobacter Species. Front Cell Infect Microbiol. 2018 Jul 24;8:243. doi: 10.3389/fcimb.2018.00243.
Gemmell MR, Berry S, Mukhopadhya I, Hansen R, Nielsen HL, Bajaj-Elliott M, et al. Comparative genomics of Campylobacter concisus: analysis of clinical strains reveals genome diversity and pathogenic potential. Emerg Microbes Infect. (2018) 7:116. doi: 10.1038/s41426-018-0118-x
Shen Z, Wang Y, Zhang Q, Shen J. Antimicrobial Resistance in Campylobacter spp. Microbiol Spectr. 2018 Apr;6(2). doi: 10.1128/microbiolspec.ARBA-0013-2017.
Han YW. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol. 2015 Feb;23:141-7. doi: 10.1016/j.mib.2014.11.013. Epub 2015 Jan 8.
Brennan CA, Garrett WS. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat Rev Microbiol. 2019 Mar;17(3):156-166. doi: 10.1038/s41579-018-0129-6.
Cueva C, Silva M, Pinillos I, Bartolomé B, Moreno-Arribas MV. Interplay between Dietary Polyphenols and Oral and Gut Microbiota in the Development of Colorectal Cancer. Nutrients. 2020 Feb 27;12(3):625. doi: 10.3390/nu12030625
Garcia-Vello P, Di Lorenzo F, Lamprinaki D, Notaro A, Speciale I, Molinaro A, et al. Structure of the O-Antigen and the Lipid A from the Lipopolysaccharide of Fusobacterium nucleatum ATCC 51191. Chembiochem. 2021 Apr 6;22(7):1252-1260. doi: 10.1002/cbic.202000751. Epub 2020 Dec 14.
Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, Devinney R, et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis. 2011 Sep;17(9):1971-8. doi: 10.1002/ibd.21606. Epub 2011 Jan 13.
Xu S, Wang HL, Xia C, Lv J, Zhang G. Associations Between Poor Oral Hygiene and Risk of Pancreatic Cancer: A Meta-analysis of Observational Studies. Pancreas. 2022 Sep 1;51(8):985-994. doi: 10.1097/MPA.0000000000002143.
Downloads
Published
Issue
Section
License
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) posterior al proceso de aprobación del manuscrito, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada.
